MEC Practice Academy 11.19
|Articles|June 17, 2021

MedPAC recommends streamlining alternative pay models

The commission says a smaller, more harmonized number of alternative pay models would result in less overlap.

The Medicare Payment Advisory Commission (MedPAC) is recommending that the Centers for Medicare & Medicaid Services (CMS) implement a smaller portfolio of alternative payment models (APM).

The recommendations come as part of MedPAC’s June 2021 Report to the Congress: Medicare and the Health Care Delivery System; released earlier this week.

The report recommends that CMS create a smaller, more harmonized portfolio of APMs which are designed to work together. This would result in less overlap, and when overlaps do exist they can be designed so that incentives do not diminish in strength when combined with other models.

MedPAC also recommends that CMS could minimize complexity by using consistent model parameters, like consistent methods for calculating spending targets and measuring quality, across the entire portfolio of APMs, according to the report.

The report notes that most of the APMs are operated by the Center for Medicare and Medicaid Innovation (CMMI) excluding the largest APM, the Medicare Shared Savings Program. The APMs under the control of CMMI are temporary demonstrations which could be expanded to permanent programs if they reduced spending in Medicare, Medicaid, or CHIP while maintaining quality care or increasing quality without increasing spending.

Since the CMMI’s establishment a decade ago, the strategy of implement a wide range of models has given the agency a chance to amass data on what works and what doesn’t, but continuing to test a lot of APMs will likely inhibit the development of APMs, the report says.


Related to this article

AMA targets downcoding, AI licensure; Jacksonville pharmacy owner indicted in $51M fraud; drug-response gene variants found in every participant — Morning Medical Update © everythingpossible - stock.adobe.com
The top news stories in medicine today: The AMA moves against insurer downcoding and says AI can't be licensed as a physician; a Jacksonville pharmacy owner is indicted in a $51 million health care fraud scheme; an NIH study finds every participant carried a gene variant that can affect drug response.
Stroke survivors get a first-of-its-kind anticoagulant; Queens day care director admits $127M Medicare, Medicaid fraud; ovarian cancer may leave an early mark in the blood — Morning Medical Update © kwanchaichaiudom - stock.adobe.com
The top news stories in medicine today: The FDA approves the first factor XIa inhibitor to reduce the risk of a repeat stroke; a Queens adult day care program director pleads guilty in a $127 million Medicare and Medicaid fraud scheme; researchers tie a blood RNA signal to the precancerous stage of ovarian cancer.